General Information
Revision date
2015-06-11
Product name
Lisinopril and Hydrochlorothiazide Tablets USP
CAS No.
83915-83-7
Manufacturer Name
Lupin Limited
Icons in SDS
Company Information
company name
Lupin Limited
Section 2
SECTION 2: Hazards identification
Fire and Explosion Health Expected to be non-combustible. Lisinopril and hydrochlorothiazide is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin- converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema. Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. Do not co-administer aliskiren with lisinopril and hydrochlorothiazide in patients with diabetes.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
